High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.

Source:http://linkedlifedata.com/resource/pubmed/id/16917214

Download in:

View as

General Info

PMID
16917214